Welcome to KOELIS®
Please choose a country or region.
KOELIS Trinity® is a leading MRI/ultrasound fusion biopsy system with demonstrated prostate biopsy accuracy as precise as 2.3 mm, as evidenced from a prospective study of Cognitive and Elastic Fusion Registration Transrectal Biopsies.1 Unlike other technologies that track the movement of the probe (robotic technology or electromagnetic sensors), KOELIS Trinity® automatically tracks patient movement and prostate deformation during the procedure –helping clinicians achieve the highest level of accuracy available.
KOELIS Trinity® delivers real-time 3D MRI/ultrasound fusion to improve prostate biopsy accuracy and cancer detection rates. The system employs our proprietary Organ-Based Tracking Fusion® (OBT) technology that tracks the prostate, not the probe. OBT Fusion® automatically compensates for patient and prostate movement with no need for an additional technician to manually realign imagery. The same prospective study concluded that deformable MR imaging/transrectal US image registration by KOELIS Trinity® achieved a higher precision and depicted cancer in more patients than the cognitive freehand technique.
1. Mean precision was 2.3 mm (95% confidence interval: 1.8 mm, 3.3 mm). Positive cores were closer to the center than were negative cores (dCC: 1.7 mm vs 3.1 mm, respectively; P = .025) https://pubmed.ncbi.nlm.nih.gov/29361246/ Precision Matters in MR Imaging-targeted Prostate Biopsies: Evidence from a Prospective Study of Cognitive and Elastic Fusion Registration Transrectal Biopsies François Cornud , Mathieu Roumiguié, Nicolas Barry de Longchamps , Guillaume Ploussard , Eric Bruguière , Daniel Portalez, Bernard Malavaud.
2. Martini, A., Cumarasamy, S., & Tewari, A. K. (2018). MRI-targeted biopsy for prostate-cancer diagnosis. N Engl J Med, 379(589), 10-1056.
© 2022 KOELIS®. All rights reserved. KOELIS Trinity® is a registered trademark of KOELIS® in certain countries.